Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDCN researchers lead a global study based on analysing survey data

Dr Arjune Sen heads up the Oxford Epilepsy Research Group. In partnership with local charity SUDEP Action, he will lead a project to investigate how COVID-19 has impacted on people with epilepsy, their carers and health care workers. In particular, they are interested in assessing escalation and mitigation of risk.

The team will be addressing this question using data from across the globe. They will employ surveys using the online JISC platform - pilot surveys are currently being reviewed and translated into multiple languages. The data will be entered anonymously and analysed in aggregated. It is hoped that as many as 500 participants will be engaged.

The aim is to use the findings to make specific recommendations on how to manage risk in people with epilepsy during the coronavirus pandemic and beyond. The team will highlight challenges and opportunities in a global context which can inform and improve patient care and help save lives.

Initially this work will be funded by the Oxfordshire Biomedical Research Centre and SUDEP Action. Collaborators include University College London and Professor Charles Newton from the Department of Psychiatry at the University of Oxford.

Similar stories

New Analysis Challenges Guidelines on Treating Anorexia Nervosa

Research Highlights

A new analysis, published in The Lancet Psychiatry, has shown a lack of strong evidence to support current guidance on psychological therapies for treating anorexia nervosa over expert treatment as usual.

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Research Highlights

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

How the brain reorganises old memories when new ones are made

Research Highlights

Researchers have discovered that the arrangement of existing memories in the brain is altered when we embed new memories

Improving Experiences of People with Serious Mental Health Problems

Research Highlights

A project led by Professor Kam Bhui and Dr Roisin Mooney, University of Oxford, will focus on reducing the number of people admitted or readmitted to compulsory care under the Mental Health Act. This is one of four new research projects funded by the National Institute for Health Research (NIHR) with the aim to improve patient experiences and outcomes under the Mental Health Act.

Potential New Target to Prevent or Delay Dementia

Research Highlights

New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.

Investigating New Treatment for Schizophrenia

Research Highlights Strategic Developments

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim has been announced to investigate a new drug target for the treatment of schizophrenia.